Want news about Allahabad Bank to land in your mailbox?

Sudarshan Sukhani's top 5 picks for today's trade
Sudarshan Sukhani of Technical Trends advises investors to buy Allahabad Bank, Cipla, ITC, Rallis India and Ranbaxy Laboratories.
Here are the key levels:
Buy Allahabad Bank with a target of Rs 140 per share and stop loss at Rs 131 per share.
It is a kind of a dark horse. Out of five, one of them usually is because banking has been underperforming. On Wednesday, banks were lower than the broad market. However, if the market decides to stage a rally, these small public sector undertaking (PSU) banks will probably join in the party. Being relatively high beta, they will participate more.
Buy Cipla with a target of Rs 330 per share and stop loss at Rs 302 per share.
There is a theme, something is going on in pharma, and this stock is making new highs and building on that. The same is happening we saw with Dr Reddy which was the choice earlier. So Cipla is also a buying opportunity and in a flat market you have to go to these stocks which usually are not momentum stocks. So it makes sense to go in for Cipla. One can buy it at the current prices and keep a stop at Rs 302. Again a target of Rs 330 is visible. Sometimes if we have a market like we saw on Wednesday, the targets may not be achieved today but they should come if the momentum is fair.
Buy ITC with a target of Rs 266 per share and stop loss at Rs 254 per share.
ITC is a buy this morning with some gains yesterday. Again they should be built on those gains. When the markets are flat relatively, these are the stocks that should give us something to play on, to trade on. ITC is a buying opportunity with a stop loss at Rs 254 and a modest target at Rs 266. However, ITC is slow and steady. It is not fast, it is not a momentum player but it is slowly moving up the ladder, Rs 1 now and Rs 2 there, slowly going up. I think ITC is a good stock to own.
Buy Rallis
Rallis is a good share to own. For the short-term, it has rallied. It seems that the rally will continue for a longer-term and for a swing trader. You can buy this share on dips with a stop loss at Rs 860 and target of Rs 1,000. For the day trader, you take whatever you get in the day. However, you might like to keep it till the close.
Buy Ranbaxy Laboratories with a target of Rs 460 per share and stop loss at Rs 410 per share.
Ranbaxy has been in a roll after that big decline. It has rallied significantly from more than Rs 250. Yesterday, it built on some gains even though the markets are flat. I think that should continue today. The stock has broken out decisively over Rs 400 range. So Ranbaxy is a buying opportunity. One should keep a stop loss at Rs 410. For a positional short-term swing trader, you can look at Rs 460. For somebody who is trading for a day take whatever gains come, one can actually hold the stock.
Continued on next page...


|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
Harsh Manglik
Chairman
Accenture India
Accenture India to hire aggressively for select verticals
Vishal Doshi
Managing Director
Shrenju & Company
Shrenuj & Company will project 15% rev rise this yr
MP Taparia
Chairman
Supreme Petrochemicals
Supreme Petrochemicals expects Rs 2200cr rev in next 1.5yrs
Vineet Nayyar
Chief Executive Officer
HCL Technologies
HCL Tech plans to merge arms with itself, eyes new spots
-
Most Read
-
Most Viewed
- Experts pick stocks/sectors for volatile mkts

- UBS Sec: Good level to enter mkts, suggests stocks

- FIIs ring India in troubled times
- What is Religare Capital betting on in the long-term?

- Buy or sell: Cheap telcos worth a call?
- How Virender Mhaiskar plans to take IRB to the next level

- NTPC FPO falters: Govt may scrutinize auction route
- Ten success stories in unheard of sectors
- US reform plan hurts global effort: Barclays CEO
- Hathway Cable IPO poorly subscribed on day 1
- China confirmed as global export champion
Source: ft.com
- Time to understand how the mighty fall
Source: ft.com
- India growth set to near 2007 boom levels
Source: ft.com
- Speculators build record bets against euro
Source: ft.com
















